Urol. praxi, 2014; 15(1): 18-21

Permanent implantation of radioactive seeds 125I in the prostate cancer treatment

MUDr.Branislav Obšitník, PhD., MUDr.Alžbeta Molnárová, MUDr.Pavol Lukačko, Mgr.Jozef Grežďo, PhD., RNDr.Kristína Poláková, PhD., MUDr.Ľuboš Bezák &dagger,

Onkologický ústav svätej Alžbety, Bratislava

Transperineal permanent implantation of radioactive seeds 125I – LDR (low dose rate) brachytherapy is according to actual guidelines for

prostate cancer treatment together with radical prostatectomy and external beam radiotherapy applicable as one of radical treatment

options (with curative intent) for men with localized low and intermediate risk prostate cancer. It´s effectiveness and low morbidity,

together with high probability for preservation of urinary continence and preservation of erectile functionare including brachytherapy

into the standard treatment options. This method is in Slovakia available from 2007 and clinical experience just confirm expectations

(until now 453 patients). Due to continuous technological development brachytherapy of prostate cancer can expect promising evolution

also in the future.

cancer treatment.

Keywords: prostate cancer, permanent implantation of radioactive seeds, brachytherapy of prostate cancer, LDR brachytherapy, prostate

Published: February 1, 2014  Show citation